Azithromycin/dexamethasone/voriconazole: Pulmonary aspergillosis following off-label use, and lack of efficacy: case report

Podobne knjige/članki

• Convalescent-anti-SARS-CoV-2-plasma/dexamethasone/voriconazole: Invasive pulmonary aspergillosis, off label use and lack of efficacy: case report
  Izdano: (2021)
• Dexamethasone: Invasive pulmonary aspergillosis following off-label use: case report
  Izdano: (2021)
• Norepinephrine/oseltamivir: Lack of efficacy and invasive pulmonary aspergillosis secondary to off-label use: case report
  Izdano: (2020)
• Multiple drugs: Invasive pulmonary aspergillosis, lack of efficacy and off-label therapy: 4 case reports
  Izdano: (2020)
• Azithromycin/favipiravir/hydroxychloroquine: Lack of efficacy and off-label use: case report
  Izdano: (2021)